SunPharm's DENSPM and DEHOP for cancer and AIDS-related diarrhea in Phase I studies.
Executive Summary
SUNPHARM POLYAMINE ANALOGS IN PHASE I CLINICALS FOR CANCER and AIDS-related chronic diarrhea, SunPharm reported Feb. 7. The Jacksonville, Fla.-based small molecule R&D firm has a total of 11 compounds in its pipeline of novel polyamine analogs, licensed exclusively worldwide from SunPharm's primary research facility at the University of Florida-Gainesville. UFL's Raymond Bergeron, MD, is the innovator of the polyamine analog technology.